Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.
Syrjänen K, Naud P, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Matos J, Gontijo R, Sarian L, Braganca J, Arlindo FC, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S. Syrjänen K, et al. Anticancer Res. 2005 Sep-Oct;25(5):3469-80. Anticancer Res. 2005. PMID: 16101165 Free article. Clinical Trial.
Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo R, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K. Sarian LO, et al. Among authors: braganca jf. J Med Screen. 2005;12(3):142-9. doi: 10.1258/0969141054855328. J Med Screen. 2005. PMID: 16156945
Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study.
Longatto-Filho A, Erzen M, Branca M, Roteli-Martins C, Naud P, Derchain SF, Hammes L, Sarian LO, Bragança JF, Matos J, Gontijo R, Lima T, Maeda MY, Tatti S, Syrjänen S, Dores G, Lörincz A, Syrjänen K. Longatto-Filho A, et al. Among authors: braganca jf. Int J Gynecol Cancer. 2006 May-Jun;16(3):955-62. doi: 10.1111/j.1525-1438.2006.00582.x. Int J Gynecol Cancer. 2006. PMID: 16803469
Human papillomavirus (HPV) infections as risk factors for cytological and histological abnormalities in baseline PAP smear-negative women followed-up for 2 years in the LAMS study.
Gontijo RC, Derchain SF, Roteli-Martins C, Bragança JF, Sarian LO, Morais SS, Maeda MY, Longatto-Filho A, Syrjänen KJ. Gontijo RC, et al. Among authors: braganca jf. Eur J Obstet Gynecol Reprod Biol. 2007 Aug;133(2):239-46. doi: 10.1016/j.ejogrb.2006.05.012. Epub 2006 Jun 30. Eur J Obstet Gynecol Reprod Biol. 2007. PMID: 16814450
Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American Screening study cohort.
Syrjänen K, Naud P, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Matos J, Gontijo R, Sarian L, Bragança J, Arlindo FC, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S. Syrjänen K, et al. Int J STD AIDS. 2008 Apr;19(4):251-8. doi: 10.1258/ijsa.2007.007179. Int J STD AIDS. 2008. PMID: 18482945
Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study.
Derchain SF, Sarian LO, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo RC, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K. Derchain SF, et al. Among authors: braganca jf. J Med Screen. 2008;15(2):97-104. doi: 10.1258/jms.2008.007061. J Med Screen. 2008. PMID: 18573778
Smoking worsens the prognosis of mild abnormalities in cervical cytology.
Guarisi R, Sarian LO, Hammes LS, Longatto-Filho A, Derchain SF, Roteli-Martins C, Naud P, Erzen M, Branca M, Tatti S, Costa S, Syrjänen S, Bragança JF, Syrjänen K. Guarisi R, et al. Among authors: braganca jf. Acta Obstet Gynecol Scand. 2009;88(5):514-20. doi: 10.1080/00016340902846072. Acta Obstet Gynecol Scand. 2009. PMID: 19308752 Free article.
33 results